Fate Therapeutics Inc (FATE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access FATE Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Fate Therapeutics Inc balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent153.80
Short-term Investments, Total121.34
Cash & Short-term Investments274.00
Accounts receivable0.70
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.48
Total Current Assets157.95
Equipment/Property/Plant Net51.55
Long-term investments0.00
Other Assets, Noncurrent50.60
Total Assets260.10
Liabilities
Accounts Payable, Current AC3.26
Accrued Liabilities, Current AC14.90
Other Liabilities, Current14.43
Total Current Liabilities32.59
Total Long-term Debt0.00
Other liabilities, Noncurrent74.07
C I R M Award Liability Current8.45
Contract With Customer Liability Current0.58
C I R M Award Liability Noncurrent2.11
Total Liabilities106.67
Stockholders' Equity
Common Stock Value0.12
Additional Paid In Capital Common Stock1,749.12
Retained Earnings / Accumulated Deficit-1,595.68
Accumulated Other Comprehensive Income-0.12
Other Equity-0.12
Common Stockholder's Equity153.44
Preferred Stockholder's Equity0.00
Total Stockholder's Equity153.44
Liabilities & Stockholder's Equity260.10
4 historic quarters locked

Sign in to unlock the full Fate Therapeutics Inc balance sheet history.

About Fate Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-347988

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.